4-Bromo-N-(4-chloro-3-methylphenyl)benzenesulfonamide, 95%, 1g

2-Ethylhexyl 4,6-Dibromo-3-fluorothieno[3,4-b]thiophene-2-carboxylate>97.0%(GC)100mg

[1-(2,3-dihydro-1,4-benzodioxin-2-yl)ethyl]amine oxalate, 95.0%, 25g

Methyl 5-fluoro-6-methoxy-1H-indole-2-carboxylate, 95.0%, 1g

tert-Butyl 6-bromohexanoate, 98.0%, 500g

3-Methyl-2-(4-oxo-2-thioxothiazolidin-3-yl)butanoic acid, 97%, 250mg

3-Methyl-2-(piperidin-3-yloxy)pyridine hydrochloride, 10g

2-(ISOBUTYLAMINO)ACETIC ACID, 95.0%, 1g

2-(4-Bromobenzyl)oxirane, 98%, 250mg

Manganese(II) chloride monohydrate, min. 99%, pa, 2.5 kg, plastic packaging.

(S)-3-Methoxypiperidine hydrochloride, 95.0%, 500mg

2-Aminopyridine-4-boronic acid pinacol ester, 95.0%, 10g

tert-Butyl (2-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)ethoxy)ethoxy)ethyl)carbamate, 95%, 50mg